Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial (vol 329, pg 296, 2023)

被引：1
|
作者：
Mccarthy, M. W.
Naggie, S.
Boulware, D. R.
机构：
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2023年 / 330卷 / 16期
关键词：
D O I：
10.1001/jama.2023.20908
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1589 / 1589
页数：1
相关论文
共 50 条
  • [21] Efficacy and Safety of Aspirin, Promethazine, and Micronutrients for Rapid Clinical Recovery in Mild to Moderate COVID-19 Patients: A Randomized Controlled Clinical Trial
    Kumar, G. Sunil
    Vadgaonkar, Atul
    Purunaik, Srilata
    Shelatkar, Rohit
    Vaidya, Vidyadhar G., Sr.
    Ganu, Gayatri
    Vadgaonkar, Aditya
    Joshi, Shashank
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [22] Evaluating the Therapeutic Effect of Sofosbuvir in Outpatients with COVID-19: A Randomized Clinical Trial Study
    Shoushtari, Maryam Haddadzadeh
    Raji, Hanieh
    Borsi, Seyed Hamid
    Tavakol, Heshmatollah
    Cheraghian, Bahman
    Moeinpour, Mahtab
    GALEN MEDICAL JOURNAL, 2024, 13
  • [23] An open label randomized clinical trial of Indomethacin for mild and moderate hospitalised Covid-19 patients
    Ravichandran, Rajan
    Mohan, Surapaneni Krishna
    Sukumaran, Suresh Kumar
    Kamaraj, Devakumar
    Daivasuga, Sumetha Suga
    Ravi, Samson Oliver Abraham Samuel
    Vijayaraghavalu, Sivakumar
    Kumar, Ramarathnam Krishna
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [24] Immunomodulatory effect of Unani polyherbal formulation- Tiryaq Wabai in mild to moderate COVID-19 patients - A randomized placebo-controlled clinical trial
    Kumar, Ansul
    Khan, Mohd Saif
    Ul Haque, Zeya
    Rai, Arpita
    Fazil, Mohammad
    Rabbani, Gulam
    JOURNAL OF AYURVEDA AND INTEGRATIVE MEDICINE, 2024, 15 (02)
  • [25] Effect of fluvoxamine on preventing neuropsychiatric symptoms of post COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial
    Ramin Hamidi Farahani
    Ali Ajam
    Alireza Ranjbar Naeini
    BMC Infectious Diseases, 23
  • [26] Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19 A Randomized Clinical Trial
    Lopez-Medina, Eduardo
    Lopez, Pio
    Hurtado, Isabel C.
    Davalos, Diana M.
    Ramirez, Oscar
    Martinez, Ernesto
    Diazgranados, Jesus A.
    Onate, Jose M.
    Chavarriaga, Hector
    Herrera, Socrates
    Parra, Beatriz
    Libreros, Gerardo
    Jaramillo, Roberto
    Avendano, Ana C.
    Toro, Dilian F.
    Torres, Miyerlandi
    Lesmes, Maria C.
    Rios, Carlos A.
    Caicedo, Isabella
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (14): : 1426 - 1435
  • [27] Effect of fluvoxamine on preventing neuropsychiatric symptoms of post COVID syndrome in mild to moderate patients, a randomized placebo-controlled double-blind clinical trial
    Farahani, Ramin Hamidi
    Ajam, Ali
    Naeini, Alireza Ranjbar
    BMC INFECTIOUS DISEASES, 2023, 23 (01)
  • [28] Operative Hysteroscopy vs Vacuum Aspiration for Incomplete Spontaneous Abortion: A Randomized Clinical Trial (vol 329, pg 1197, 2023)
    Kavanagh, P. L.
    Fasipe, T.
    Wun, T.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (12): : 1194 - 1194
  • [29] Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19 A Randomized Clinical Trial
    Gottlieb, Robert L.
    Nirula, Ajay
    Chen, Peter
    Boscia, Joseph
    Heller, Barry
    Morris, Jason
    Huhn, Gregory
    Cardona, Jose
    Mocherla, Bharat
    Stosor, Valentina
    Shawa, Imad
    Kumar, Princy
    Adams, Andrew C.
    Van Naarden, Jacob
    Custer, Kenneth L.
    Durante, Michael
    Oakley, Gerard
    Schade, Andrew E.
    Holzer, Timothy R.
    Ebert, Philip J.
    Higgs, Richard E.
    Kallewaard, Nicole L.
    Sabo, Janelle
    Patel, Dipak R.
    Klekotka, Paul
    Shen, Lei
    Skovronsky, Daniel M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (07): : 632 - 644
  • [30] Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19 A Randomized Clinical Trial
    Spinner, Christoph D.
    Gottlieb, Robert L.
    Criner, Gerard J.
    Arribas Lopez, Jose Ramon
    Cattelan, Anna Maria
    Soriano Viladomiu, Alex
    Ogbuagu, Onyema
    Malhotra, Prashant
    Mullane, Kathleen M.
    Castagna, Antonella
    Chai, Louis Yi Ann
    Roestenberg, Meta
    Tsang, Owen Tak Yin
    Bernasconi, Enos
    Le Turnier, Paul
    Chang, Shan-Chwen
    SenGupta, Devi
    Hyland, Robert H.
    Osinusi, Anu O.
    Cao, Huyen
    Blair, Christiana
    Wang, Hongyuan
    Gaggar, Anuj
    Brainard, Diana M.
    McPhail, Mark J.
    Bhagani, Sanjay
    Ahn, Young
    Sanyal, Arun J.
    Huhn, Gregory
    Marty, Francisco M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (11): : 1048 - 1057
12345